HSR26-201: Implications of Interleukin-6 Levels in Hospitalized Patients With COVID-19: Impact of Cancer Status on Mortality
Journal of the National Comprehensive Cancer Network · 31.03.2026 · 24 (3.5)
DOI: 10.6004/jnccn.2025.7472 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the National Comprehensive Cancer Network, erschienen am 31.03.2026. Verfasst von Muzammil Dastagir und 9 weiteren Autor:innen. Beteiligte Einrichtung: 1University of Texas at San Antonio, TX.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- 1University of Texas at San Antonio, TX.
- 2South Texas Veterans Health Care System, San Antonio, TX.
- 3GRECC, San Antonio, TX.
Zitieren
APA
Dastagir, M., Bhargava, S., Peterson, L., Trinh, H., Mader, M. J., Lee, G. C., Harper, N., Ahuja, S., Sanchez-Reilly, S., & Restrepo, M. I. (2026). HSR26-201: Implications of Interleukin-6 Levels in Hospitalized Patients With COVID-19: Impact of Cancer Status on Mortality. Journal of the National Comprehensive Cancer Network, 24(3.5). https://doi.org/10.6004/jnccn.2025.7472
Vancouver
Dastagir M, Bhargava S, Peterson L, Trinh H, Mader MJ, Lee GC, et al. HSR26-201: Implications of Interleukin-6 Levels in Hospitalized Patients With COVID-19: Impact of Cancer Status on Mortality. Journal of the National Comprehensive Cancer Network. 2026;24(3.5). doi:10.6004/jnccn.2025.7472
BibTeX
@article{Dastagir2026,
author = {Dastagir, Muzammil and Bhargava, Supriya and Peterson, Lauren and Trinh, Hanh and Mader, Michael J and Lee, Grace C and Harper, Nathan and Ahuja, Sunil and Sanchez-Reilly, Sandra and Restrepo, Marcos I},
title = {HSR26-201: Implications of Interleukin-6 Levels in Hospitalized Patients With COVID-19: Impact of Cancer Status on Mortality},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2026},
volume = {24},
number = {3.5},
doi = {10.6004/jnccn.2025.7472}
}
EUVIMED